169 related articles for article (PubMed ID: 12955091)
1. Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.
Rippe V; Drieschner N; Meiboom M; Murua Escobar H; Bonk U; Belge G; Bullerdiek J
Oncogene; 2003 Sep; 22(38):6111-4. PubMed ID: 12955091
[TBL] [Abstract][Full Text] [Related]
2. A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors.
Rippe V; Belge G; Meiboom M; Kazmierczak B; Fusco A; Bullerdiek J
Genes Chromosomes Cancer; 1999 Nov; 26(3):229-36. PubMed ID: 10502321
[TBL] [Abstract][Full Text] [Related]
3. A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas.
Drieschner N; Kerschling S; Soller JT; Rippe V; Belge G; Bullerdiek J; Nimzyk R
Gene; 2007 Nov; 403(1-2):110-7. PubMed ID: 17889454
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
Drieschner N; Belge G; Rippe V; Meiboom M; Loeschke S; Bullerdiek J
Thyroid; 2006 Nov; 16(11):1091-6. PubMed ID: 17123335
[TBL] [Abstract][Full Text] [Related]
5. Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region.
Belge G; Garcia E; Rippe V; Fusco A; Bartnitzke S; Bullerdiek J
Genes Chromosomes Cancer; 1997 Oct; 20(2):201-3. PubMed ID: 9331571
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenetic changes in benign thyroid gland hyperplasias and adenomas correlated with histology].
Belge G; Roque L; Thode B; Fonseca E; Soares J; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
Verh Dtsch Ges Pathol; 1997; 81():151-6. PubMed ID: 9474866
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb.
Bol S; Belge G; Rippe V; Bullerdiek J
Cytogenet Cell Genet; 2001; 95(3-4):189-91. PubMed ID: 12063398
[TBL] [Abstract][Full Text] [Related]
8. CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas.
Asp J; Persson F; Kost-Alimova M; Stenman G
Genes Chromosomes Cancer; 2006 Sep; 45(9):820-8. PubMed ID: 16736500
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic profile of 109 lipomas.
Sreekantaiah C; Leong SP; Karakousis CP; McGee DL; Rappaport WD; Villar HV; Neal D; Fleming S; Wankel A; Herrington PN
Cancer Res; 1991 Jan; 51(1):422-33. PubMed ID: 1988102
[TBL] [Abstract][Full Text] [Related]
10. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas.
Rippe V; Dittberner L; Lorenz VN; Drieschner N; Nimzyk R; Sendt W; Junker K; Belge G; Bullerdiek J
PLoS One; 2010 Mar; 5(3):e9485. PubMed ID: 20209130
[TBL] [Abstract][Full Text] [Related]
11. [From the cytogenetics to the cytogenomics of thyroid tumors].
Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P
Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859
[TBL] [Abstract][Full Text] [Related]
12. Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12).
Röijer E; Kas K; Klawitz I; Bullerdiek J; Van de Ven W; Stenman G
Genes Chromosomes Cancer; 1996 Nov; 17(3):166-71. PubMed ID: 8946195
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
[TBL] [Abstract][Full Text] [Related]
14. Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.
Belge G; Rippe V; Meiboom M; Drieschner N; Garcia E; Bullerdiek J
Cytogenet Cell Genet; 2001; 93(1-2):48-51. PubMed ID: 11474178
[TBL] [Abstract][Full Text] [Related]
15. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
[TBL] [Abstract][Full Text] [Related]
16. A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas.
Meiboom M; Murua Escobar H; Pentimalli F; Fusco A; Belge G; Bullerdiek J
Cytogenet Genome Res; 2003; 101(2):113-7. PubMed ID: 14610350
[TBL] [Abstract][Full Text] [Related]
17. Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12.
Stenman G; Sahlin P; Mark J; Landys D
Oncogene; 1991 Jul; 6(7):1105-8. PubMed ID: 1677749
[TBL] [Abstract][Full Text] [Related]
18. On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid.
Klemke M; Drieschner N; Laabs A; Rippe V; Belge G; Bullerdiek J; Sendt W
Cancer Genet; 2011 Jun; 204(6):334-9. PubMed ID: 21763631
[TBL] [Abstract][Full Text] [Related]
19. Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors.
Belge G; Bruckmann S; Thode B; Bartnitzke S; Bullerdiek J
Genes Chromosomes Cancer; 1996 Jun; 16(2):149-51. PubMed ID: 8818663
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal assignment of canine THADA gene to CFA 10q25.
Soller JT; Beuing C; Murua Escobar H; Winkler S; Reimann-Berg N; Drieschner N; Dolf G; Schelling C; Nolte I; Bullerdiek J
Mol Cytogenet; 2008 Jun; 1():11. PubMed ID: 18522714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
